Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MYST2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA560723
Description
Immunogen sequence: GCNSLGHLTG KHERHFSISG CPLYHNLSAD ECKAPTERQL RYKEKVAELR KKRNSGLSKE QKEKYMEHRQ TYGNTREPLL ENLTSEYDLD LFRRAQARAS EDLEKLRLQG QITEGSNM Highest antigen sequence identity to the following orthologs: Mouse - 100%, Rat - 49%.
This gene encodes a member of the hepatoma-derived growth factor family. The encoded protein has mitogenic and DNA-binding activity and may play a role in cellular proliferation and differentiation. This gene was thought initially to be located on chromosome X, however, that location has been determined to correspond to a related pseudogene. Alternatively spliced transcript variants encoding distinct isoforms have been described.
Specifications
MYST2 | |
Polyclonal | |
Unconjugated | |
Kat7 | |
EC 2.3.1.48; HBO1; HBOa; histone acetyltransferase binding to ORC1; Histone acetyltransferase KAT7; histone acetyltransferase MYST2; K (lysine) acetyltransferase 7; K(lysine) acetyltransferase 7; Kat7; Lysine acetyltransferase 7; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2; MYST histone acetyltransferase 2; MYST protein 2; MYST2; MYST-2; ZC2HC7 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
11143, 217127, 303470 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.4 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
O95251, Q5SVQ0, Q810T5 | |
Kat7 | |
Recombinant protein corresponding to Human MYST2. Recombinant protein control fragment (Product #RP-102520). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction